This article has Open Peer Review reports available.
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
© The Author(s). 2017
Received: 1 November 2016
Accepted: 17 March 2017
Published: 24 March 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|1 Nov 2016||Submitted||Original manuscript|
|10 Nov 2016||Author responded||Author comments - Marie Buchholz|
|Resubmission - Version 2|
|10 Nov 2016||Submitted||Manuscript version 2|
|15 Dec 2016||Reviewed||Reviewer Report - Alexander Beatty|
|22 Dec 2016||Reviewed||Reviewer Report - Linara Gabitova|
|20 Jan 2017||Author responded||Author comments - Marie Buchholz|
|Resubmission - Version 3|
|20 Jan 2017||Submitted||Manuscript version 3|
|9 Mar 2017||Author responded||Author comments - Marie Buchholz|
|Resubmission - Version 4|
|9 Mar 2017||Submitted||Manuscript version 4|
|17 Mar 2017||Editorially accepted|
|24 Mar 2017||Article published||10.1186/s12885-017-3204-x|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.